5'-O-(N-(Alanyl)sulfamoyl)adenosine

**5'-O-(N-(Alanyl)sulfamoyl)adenosine** is a synthetic purine nucleoside analog and an experimental small molecule compound. It consists of an adenosine core modified at the 5' position with a sulfamoyl group linked to an alanyl moiety. The compound is not approved for clinical use and has no known marketed indications or completed clinical trials. Its primary research interest lies in its role as a molecular probe or inhibitor in biochemical studies involving aminoacyl-tRNA synthetases and related enzymatic pathways. The mechanism of action is presumed to involve competitive inhibition of enzymes that utilize adenosine derivatives as substrates or cofactors[1][9]. No evidence exists for therapeutic development beyond preclinical/experimental settings.

Other names

5'-O-[N-(L-alanyl)sulfamoyl]adenosineAdenosine,5'-[N-[(2S)-2-amino-1-oxopropyl]sulfamate](2S)-2-amino-1-[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2 yl]methoxy}sulfonyl)amino]propan 1-one((2R,3S,4R,5R)-5-(6-Amino–9H-purin–9–yl)–3,4-dihydroxytetrahydrofuran–2 yl)methyl ((S)–2 aminopropanoyl)sulfamate